Postnatal lead exposure and the cholinergic system
Related Experiment Video
Updated: Oct 23, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Insights
Early lead (Pb) exposure in rats impaired learning and memory. Cholinergic drug treatments reversed these effects, suggesting lead-induced behavioral changes stem from impaired cholinergic function.
Area of Science:
- Neuroscience
- Toxicology
- Behavioral Science
Background:
- Early lead (Pb) exposure is linked to behavioral deficits.
- Cholinergic system dysfunction has been proposed as a mechanism for these effects.
Purpose of the Study:
- To investigate the role of cholinergic function in the behavioral effects of early lead exposure.
- To determine if modulating cholinergic activity can ameliorate lead-induced behavioral impairments.
Main Methods:
- Long-Evans hooded rat pups were exposed to lead (High Pb, low Pb, or control) via maternal milk for 25 days.
- Animals were behaviorally tested at 65 days of age using tasks assessing passive avoidance, spontaneous alternation, and open field activity.
- The effects of cholinergic agonist (physostigmine) and antagonist (scopolamine) were examined in control and lead-exposed rats.
Main Results:
- Lead exposure impaired passive avoidance acquisition and spontaneous alternation but not open field activity.
- Physostigmine improved behavioral deficits in lead-exposed rats.
- Scopolamine mimicked some lead-induced deficits in control rats and showed complex effects in lead-exposed rats, suggesting an inverted U-shaped dose-response.
Conclusions:
- Behavioral responses of lead-exposed rats are consistent with cholinergic deficiency.
- These findings provide further evidence for the involvement of the cholinergic system in the behavioral consequences of early lead exposure.
Abstract:
Previous reports have suggested that the behavioral effects of early lead (Pb) exposure may be due to an underlying deficiency in cholinergic function. To further examine this possibility, Long-Evans hooded rat pups were exposed to Pb for the first 25 postnatal days via the maternal milk. Dams were fed either 4.0% PbCO3 (High Pb), 0.4% PbCO3 (low Pb) or a Na2CO3 control diet throughout this period. Beginning at 65 days of age, animals were tested on behavioral tasks sensitive to both Pb exposure and cholinergic deficiency. Exposure to both levels of Pb impaired passive avoidance acquisition and produced lower rates of spontaneous alternation. Pb, however, had no clear effects on open field activity. The cholinergic agonist physostigmine (0.05 and 0.075 mg/kg) did not affect the behavior of control animals on any task, but in both Pb exposed groups physostigmine improved passive avoidance acquisition, increased the rate of spontaneous alternation and lowered open field activity scores. The cholinergic antagonist scopolamine (0.4 mg/kg) impaired passive avoidance acquisition, lowered the rate of spontaneous alternation and increased open field activity scores in control animals. Consistent with behavior characteristic of an inverted U shaped response curve, scopolamine (0.2 and 0.4 mg/kg) improved passive avoidance acquisition in both Pb exposed groups and decreased open field activity scores in the High Pb group. In all cases, the behavioral response of the Pb exposed animals may be interpreted as responses characteristic of cholinergically deficient animals. These results thus provide further evidence for cholinergic system involvement in the behavioral changes observed following early exposure to Pb.
More Related Videos
07:36Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
03:19Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes
Published on: June 28, 2024
Related Concept Videos
Toxic Reactions: Overview
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Cholinergic Neurons: Neurotransmission
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.